Skip to main content

Table 2 classes of antibiotic prescribed among hospitalized patients based on the indications

From: Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey

Classes of antibioticFrequency (%)
TotalCIHISPMPUI
Nitroimidazoles128 (28.5)46 (26.4)23 (31.5)34 (33.7)13 (19.4)12 (35.3)
Third generation cephalosporins85 (18.9)26 (14.9)15 (20.5)21 (20.8)16 (23.9)7 (20.6)
Fluoroquinolones61 (13.6)33 (19.0)8 (11.0)8 (7.9)5 (7.5)7 (20.6)
Penicillins – beta lactamase inhibitors47 (10.5)18 (10.3)8 (11.0)11 (10.9)7 (10.4)3 (8.8)
Aminoglycosides38 (8.5)13 (7.5)10 (13.7)4 (4.0)10 (14.9)1 (2.9)
Penicillins38 (8.5)11 (6.3)4 (5.5)8 (7.9)12 (17.9)3 (8.8)
Second generation cephalosporins17 (3.8)6 (3.4)2 (2.7)9 (8.9)0 (0.0)0 (0.0)
Lincosamides14 (3.1)9 (5.2)1 (1.4)3 (3.0)1 (1.5)0 (0.0)
Macrolides8 (1.8)6 (3.4)0 (0.0)1 (1.0)1 (1.5)0 (0.0)
Sulphonamides4 (0.9)2 (1.1)1 (1.4)0 (0.0)1 (1.5)0 (0.0)
Tetracyclines4 (0.9)1 (0.6)0 (0.0)2 (2.0)0 (0.0)1 (2.9)
Amphenicols3 (0.7)3 (1.7)0 (0.0)0 (0.0)0 (0.0)0 (0.0)
Carbapenems1 (0.2)0 (0.0)1 (1.4)0 (0.0)0 (0.0)0 (0.0)
Nitrofuran derivatives1 (0.2)0 (0.0)0 (0.0)0 (0.0)1 (1.5)0 (0.0)
Proportion of broad spectrum antibiotics147 (32.7)59 (33.9)32 (43.8)42 (41.6)21 (31.3)14 (41.2)
  1. CI Community acquired infections, HI Hospital acquired infections, SP Surgical prophylaxis, MP Medical prophylaxis and UI Unknown indication